199
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Effect of Natural 2,5-Diaryl-3,4-dimethyltetrahydrofuran Lignans on Complement Activation, Lymphocyte Proliferation, and Growth of Tumor Cell Lines

, , , , , & show all
Pages 449-453 | Published online: 29 Sep 2008
 

Abstract

(+)-Machillin F, isolated from the bark of Persea membranacea, Kosterm and four other 2,5-diaryl-3,4-dimethyltetrahydrofuran-type lignans from Talauma hodgsonii Hook, F. & Thoms., (−)-galbacin, (−)-talaumidin, (−)-talaumidin methyl ether, and acetyl talaumidin, were evaluated for their influence on the classical and alternative pathways of activation of human complement system, mitogen-induced proliferation of human lymphocytes, and growth of human tumor cell lines. All these lignans exhibited moderate inhibitory activities. (+)-Machillin F showed the highest anticomplementary activity, and (−)-talaumidin methyl ether exhibited the strongest suppressive effect on lymphocyte proliferation. (−)-Talaumidin, acetyl talaumidin, and (+)-machillin F inhibited the growth of MCF-7, TK-10, and UACC-62 cell lines, whereas (−)-galbacin was inactive against UACC-62 and (−)-talaumidin methyl was inactive against both TK-10 and UACC-62. A characterization of the structural features of these lignans that is important to their biological activities is discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.